The life and work of Judson T. Chesterman, pioneering cardiac surgeon.

Autor: Parker WAE; Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK.; Faculty of the History and Philosophy of Medicine and Pharmacy, Worshipful Society of Apothecaries, London, UK.

Publikováno v: Journal of medical biography [J Med Biogr] 2024 Oct 07, pp. 9677720241287972. Date of Electronic Publication: 2024 Oct 07.

Coagulation Disorders and Thrombotic Complications in Heart Failure With Preserved Ejection Fraction.

Autor: Karaban K; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Słupik D; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Reda A; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Gajewska M; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Rolek B; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland., Borovac JA; Division of Interventional Cardiology, Cardiovascular Diseases Department, University Hospital of Split, Split, Croatia., Papakonstantinou PE; Second Cardiology Department, Evangelismos Hospital, Athens, Greece; First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece., Bongiovanni D; Department of Internal Medicine I, Cardiology, University Hospital Augsburg, University of Augsburg, Augsburg, Germany; Department of Cardiovascular Medicine, Humanitas Clinical and Research Center IRCCS and Humanitas University, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Department of Cardiovascular Medicine, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Ehrlinder H; Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden., Parker WAE; Cardiovascular Research Unit, Division of Clinical Medicine, University of Sheffield, Sheffield, UK., Siniarski A; Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, Cracow, Poland; John Paul II Hospital, Cracow, Poland., Gąsecka A; Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland. Electronic address: aleksandra.gasecka@wum.edu.pl.

Publikováno v: Current problems in cardiology [Curr Probl Cardiol] 2024 Jan; Vol. 49 (1 Pt C), pp. 102127. Date of Electronic Publication: 2023 Oct 05.

Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum.

Autor: Varian FL; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK and., Parker WAE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK and., Fotheringham J; School of Health and Related Research, University of Sheffield, Sheffield, UK., Storey RF; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK and.

Publikováno v: Platelets [Platelets] 2023 Dec; Vol. 34 (1), pp. 2154330.

Thrombotic Coronary Occlusion and Reperfusion: Unraveling the Determinants.

Autor: Storey RF; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom; South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom. Electronic address: r.f.storey@sheffield.ac.uk., Parker WAE; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom; South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2023 May 16; Vol. 81 (19), pp. 1933-1936.

Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes.

Autor: Parker WAE; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK. Electronic address: w.parker@sheffield.ac.uk., Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA., Rollini F; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA., Franchi F; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA., Bonaca MP; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Steg PG; Université Paris-Cité, INSERM UMR1148/LVTS, AP-HP, Hôpital Bichat, Paris, France., Orme RC; Department of Cardiology, St John of God Hospital, Southwest Health Campus, Bunbury, WA, Australia., Thomas MR; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Judge HM; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Storey RF; Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

Publikováno v: Vascular pharmacology [Vascul Pharmacol] 2023 Apr; Vol. 149, pp. 107145. Date of Electronic Publication: 2023 Jan 28.